Takeda zika virus

Ended Definitive Contract Awarded Last action

Contract number
HHSO100201600015C
Awardee
Awarding agency
Obligated
$100,440,882

Award facts

Opportunity
  • BARDABAA16100SOL0000 Solicitation number
Contract value 30% obligated
  • $100,440,881.74 Current, with exercised options
  • $335,333,551.74 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Cost Plus Fixed Fee
Place of performance
Japan

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00018 · To deobligate $7,416,267.20 in unused funds -$7,416,267
Supplemental Agreement for work within scope P00017 $0
Supplemental Agreement for work within scope P00016 · This administrative modification is to extend the period of performance at no cost to the government for option period 5 and option 6. The approved extension to… $0
Other Administrative Action P00015 · Contractor not eligible for IPP. $0
Other Administrative Action P00014 · This is an administrative action to deobligate funding only -$92,041
Supplemental Agreement for work within scope P00013 $0
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Exercise an Option P00009 $19,447,870
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Supplemental Agreement for work within scope 6 $0
Exercise an Option 5 $17,548,964
Exercise an Option 4 $12,039,780
Exercise an Option 3 $29,243,206
Change Order 2 · Takeda zika virus this bilateral modification is issued pursuant to far 43.103(a). The purpose of this modification is to obligate additional funding in the… $9,867,376
Supplemental Agreement for work within scope 1 $0
Original award $19,801,994
Show all 19

About this award

Written by GovTribe AI ·

This is a $335,333,551.74 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Takeda Vaccines Inc. for the development of a Zika virus vaccine. The contract has a period of performance through September 30, 2024. It is a cost-plus-fixed-fee contract with no set-aside designation.

The contract supports ASPR's Zika virus research and vaccine development initiatives. As the prime contractor, Takeda Vaccines Inc. is leading the effort and has engaged a number of subcontractors to provide specialized services such as:

  • IQVIA Government Solutions Inc. for Zika-specific assay development, qualification, and validation
  • University of Pittsburgh for research on Zika virus neutralizing antibodies
  • Charles River Laboratories, Alpha Genesis, and other CROs for animal model studies and virology testing

This major contract award reflects the U.S. government's ongoing focus on enhancing pandemic preparedness and developing medical countermeasures against emerging infectious disease threats like Zika virus.

Subawards

Subcontractor Amount Awarded
Iqvia Government Solutions Inc. THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $65,000
Serimmune Inc. THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $46,180
University Of Pittsburgh - Of The Commonwealth System Of Higher Education THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $150,000
Iqvia Government Solutions Inc. THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $194,730
Yale Univ THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $417,912
Q Squared LLC THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $46,600
Eurofins Viracor, LLC THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $88,116
Charles River Laboratories, Inc. THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $40,635
Iqvia Government Solutions Inc. THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $649,118
Subcontractor not on record This administrative modification is to extend the period of performance at no cost to the government for option period 5 and option 6. The approved extension to… $148,010
Eurofins Viracor, LLC THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $148,010
Novotech Drug Development Consulting LLC THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $183,000
Alpha Genesis Inc. THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $120,500
Charles River Laboratories, Inc. This administrative modification is to extend the period of performance at no cost to the government for option period 5 and option 6. The approved extension to… $233,545
Iqvia Government Solutions Inc. THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $252,150
Y-Prime, LLC THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $253,670
Subcontractor not on record THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $84,925
Alpha Genesis Inc. THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $74,940
Subcontractor not on record This administrative modification is to extend the period of performance at no cost to the government for option period 5 and option 6. The approved extension to… $317,817
Subcontractor not on record THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $198,845
Iqvia Government Solutions Inc. THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $168,511
Alpha Genesis Inc. THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $125,213
Subcontractor not on record THIS ADMINISTRATIVE MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT FOR OPTION PERIOD 5 AND OPTION 6. THE APPROVED EXTENSION TO… $38,600
Show all 23

Quick answers

Who was awarded contract HHSO100201600015C?

HHSO100201600015C was awarded to Takeda Vaccines Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 31, 2016.

How much is contract HHSO100201600015C worth?

The government has obligated $100,440,882 on HHSO100201600015C. Its potential value, with all options, is $335,333,552.

Was contract HHSO100201600015C competed?

The extent of competition for HHSO100201600015C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login